Clinical Trials Browser

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Borderline Resectable Pancreatic Adenocarcinoma

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Anus Neoplasms

Pancreatic Adenocarcinoma

Esophageal Neoplasms

Rectal Neoplasms

Locally Advanced Rectal Cancer

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma

Pancreatic Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms

Esophageal Neoplasms, Esophagitis

Rectal Neoplasms

Esophageal Squamous Cell Carcinoma

Rectal Neoplasms

Anal Canal Carcinoma, Anus Neoplasms

Rectal Neoplasms

Anus Neoplasms

Esophageal Neoplasms

Rectal Neoplasms

Diabetes Mellitus, Insulin-Dependent, 12, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Rectal Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Adenocarcinoma of the Esophagogastric Junction

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms

Rectal Neoplasms

Esophageal Neoplasms

Rectal Neoplasms

Stomach Neoplasms

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

Neoplasm Metastasis, Pancreatic Neoplasms

Pancreatic Neoplasms

Stomach Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Rectal Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Diseases, Esophageal Neoplasms

Esophageal Neoplasms, Neoplasms

Rectal Neoplasms

Esophageal Neoplasms

Esophageal Neoplasms

Stomach Neoplasms

Clinical Trials

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer

Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer

Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases

Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

NLCCRIT-LARC

A Study of Patients Receiving High-Dose Rate Brachytherapy

Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer

Niraparib + Dostarlimab + RT in Pancreatic Cancer

Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC

TRACER

PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients

TORCH-R

RADIANCE

Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer

Short-course Radiotherapy Combined With CapeOx and PD-1 Inhibitor After Local Excision for High-risk Early Rectal Cancer (TORCH-LE)

A Phase II Study of CRT Combined With QL1706 in ESCC Patients

Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer

Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

MEMORI

Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer

Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.

Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer

S-1 and Radiotherapy for Elderly Esophageal Cancer Patients

AMBITION

Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma

Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer

FOLRT

Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer

REVO

NORMAL-R

Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer

Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer

Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer

Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer

Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma

Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer

Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)

TOXAG